blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1601646

EP1601646 - 2-SUBSTITUTED VITAMIN D ANALOGUES AND THEIR THERAPEUTIC USES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.06.2012
Database last updated on 03.10.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
K.U. Leuven Research and Development
Groot Begijnhof 58
3000 Leuven / BE
For all designated states
Universiteit Gent
Sint-Pietersnieuwstraat 25
9000 Gent / BE
[N/P]
Former [2005/49]For all designated states
K.U. Leuven Research and Development
Groot Begijnhof 58
3000 Leuven / BE
For all designated states
Universiteit Gent
Sint-Pietersnieuwstraat 25
9000 Gent / BE
Inventor(s)01 / BOUILLON, Roger
Schoonzichtlaan 22
B-3020 Winksele / BE
02 / VERSTUYF, Annemieke
Patrijzenlaan 7
B-3050 Oud-Heverlee / BE
03 / VANDEWALLE, Maurits
Nekkersberglaan 7
B-9000 Gent / BE
04 / DE CLERCQ, Pierre
Vijvermeerspark 17
B-9000 Gent / BE
 [2005/49]
Representative(s)Bird, Ariane, et al
Bird Goën & Co
Wetenschapspark Arenberg
Gaston Geenslaan 9
3001 Heverlee / BE
[N/P]
Former [2005/49]Bird, Ariane, et al
Bird Goen & Co, Klein Dalenstraat 42A
3020 Winksele / BE
Application number, filing date04718886.710.03.2004
[2005/49]
WO2004BE00037
Priority number, dateGB2003000533210.03.2003         Original published format: GB 0305332
[2005/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004080922
Date:23.09.2004
Language:EN
[2004/39]
Type: A2 Application without search report 
No.:EP1601646
Date:07.12.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 23.09.2004 takes the place of the publication of the European patent application.
[2005/49]
Type: B1 Patent specification 
No.:EP1601646
Date:27.07.2011
Language:EN
[2011/30]
Search report(s)International search report - published on:EP09.12.2004
ClassificationIPC:C07C401/00, A61K31/59, A61P35/00, A61P19/08, A61P19/10
[2005/49]
CPC:
C07C401/00 (EP,US); A61P17/00 (EP); A61P19/00 (EP);
A61P19/08 (EP); A61P19/10 (EP); A61P29/00 (EP);
A61P35/00 (EP); A61P37/02 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2005/49]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:2-SUBSTITUIERTE VITAMIN D ANALOGEN UND IHRE THERAPEUTISCHE ANWENDUNGEN[2005/49]
English:2-SUBSTITUTED VITAMIN D ANALOGUES AND THEIR THERAPEUTIC USES[2005/49]
French:ANALOGUES DE LA VITAMINE D ET LEURS UTILISATIONS THERAPEUTIQUES[2005/49]
Entry into regional phase13.09.2005National basic fee paid 
13.09.2005Designation fee(s) paid 
13.09.2005Examination fee paid 
Examination procedure04.02.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.09.2005Examination requested  [2005/49]
29.11.2005Amendment by applicant (claims and/or description)
09.07.2009Despatch of a communication from the examining division (Time limit: M06)
19.01.2010Reply to a communication from the examining division
26.02.2010Despatch of a communication from the examining division (Time limit: M04)
08.07.2010Reply to a communication from the examining division
05.11.2010Cancellation of oral proceeding that was planned for 10.12.2010
10.12.2010Date of oral proceedings (cancelled)
15.02.2011Communication of intention to grant the patent
10.06.2011Fee for grant paid
10.06.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.07.2009
Opposition(s)02.05.2012No opposition filed within time limit [2012/27]
Fees paidRenewal fee
13.09.2005Renewal fee patent year 03
30.03.2007Renewal fee patent year 04
03.03.2008Renewal fee patent year 05
09.03.2009Renewal fee patent year 06
24.02.2010Renewal fee patent year 07
24.02.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.03.2004
CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
TR27.07.2011
BG27.10.2011
[2014/34]
Former [2014/21]CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
TR27.07.2011
BG27.10.2011
Former [2013/29]CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
BG27.10.2011
Former [2013/10]CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
Former [2012/49]CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
CY10.03.2012
Former [2012/23]CZ27.07.2011
EE27.07.2011
RO27.07.2011
SK27.07.2011
Former [2012/21]CZ27.07.2011
Cited inInternational search[Y]US5936105  (PAAREN HERBERT E [US]) [Y] 1,2,4-8,10-19 * column 4, line 35 * * column 3, lines 61-63 * * column 25, lines 33-63 *;
 [Y]  - SICINSKI RAFAL R ET AL, "2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvita min D3: Synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain", JOURNAL OF MEDICINAL CHEMISTRY, (20020801), vol. 45, no. 16, ISSN 0022-2623, pages 3366 - 3380, XP002291416 [Y] 1,2,4-8,10-19 * page 3367; examples 4-7 * * page 3372; table 1 * * page 3373; table 2 *

DOI:   http://dx.doi.org/10.1021/jm020007m
 [Y]  - POSNER GARY H ET AL, "2,2-disubstituted analogues of the natural hormone 1alpha,25-dihydroxyvitamin D3: Chemistry and biology", BIOORGANIC AND MEDICINAL CHEMISTRY, (200207), vol. 10, no. 7, ISSN 0968-0896, pages 2353 - 2365, XP002291417 [Y] 1,2,4-8,10-19 * page 2354; examples 8a-d * * page 2357, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0968-0896(02)00058-5
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.